| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.25 | 0.01 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.01 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.02 |